RNAi: gene-silencing in therapeutic intervention

被引：111
|
作者：
Shuey, DJ [1 ]
McCallus, DE [1 ]
Giordano, T [1 ]
机构：
[1] Nucleon, Malvern, PA 19355 USA
来源：
DRUG DISCOVERY TODAY | 2002年 / 7卷 / 20期
关键词：
D O I：
10.1016/S1359-6446(02)02474-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Several rapidly developing RNA interference (RNAi) methodologies hold the promise to selectively inhibit gene expression in mammals. RNAi is an innate cellular process activated when a double-stranded RNA (dsRNA) molecule of greater than 19 duplex nucleotides enters the cell, causing the degradation of not only the invading dsRNA molecule, but also single-stranded (ssRNAs) RNAs of identical sequences, including endogenous mRNAs. As such, RNAi technology is currently being evaluated not only as an extremely powerful instrument for functional genomic analyses, but also as a potentially useful method to develop highly specific dsRNA based gene-silencing therapeutics.
引用
收藏
页码：1040 / 1046
页数：7
相关论文
共 50 条
  • [21] Tetrahedral DNAzymes for enhanced intracellular gene-silencing activity
    Hien Bao Dieu Thai
    Levi-Acobas, Fabienne
    Yum, Soo-Young
    Jang, Goo
    Hollenstein, Marcel
    Ahn, Dae-Ro
    CHEMICAL COMMUNICATIONS, 2018, 54 (68) : 9410 - 9413
  • [22] DNAzyme as a rising gene-silencing agent in theranostic settings
    Zhang, Nan
    NEURAL REGENERATION RESEARCH, 2022, 17 (09) : 1989 - 1990
  • [23] Behind the scenes of a small RNA gene-silencing pathway
    Ku, Gregory
    McManus, Michael T.
    HUMAN GENE THERAPY, 2008, 19 (01) : 17 - 26
  • [24] DNAzyme as a rising gene-silencing agent in theranostic settings
    Nan Zhang
    Neural Regeneration Research, 2022, 17 (09) : 1989 - 1990
  • [25] New Aspects of Gene-Silencing for the Treatment of Cardiovascular Diseases
    Koenig, Olivia
    Walker, Tobias
    Perle, Nadja
    Zech, Almuth
    Neumann, Bernd
    Schlensak, Christian
    Wendel, Hans-Peter
    Nolte, Andrea
    PHARMACEUTICALS, 2013, 6 (07): : 881 - 914
  • [26] Lentiviral gene-silencing vectors and their potential for gene therapy in promyelocytic leukaemia
    Casey, Nicholas
    Woods, Greg
    HUMAN GENE THERAPY, 2008, 19 (10) : 1105 - 1105
  • [27] Overcoming Drawbacks of Gene Silencing with RNAi
    Schmitt, Kathrin
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2012, 32 (21): : 40 - 41
  • [28] RNAi and heterochromatic gene silencing.
    Volpe, TA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U171 - U171
  • [29] RNAi gene silencing applications advance
    Glaser, Vicki
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (02): : 28 - +
  • [30] Transcription and RNAi in heterochromatic gene silencing
    Buehler, Marc
    Moazed, Danesh
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2007, 14 (11) : 1041 - 1048
12345